Baxter Nancy N, Hartman Lacey K, Tepper Joel E, Ricciardi Rocco, Durham Sara B, Virnig Beth A
Department of Surgery, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
Ann Surg. 2007 Apr;245(4):553-9. doi: 10.1097/01.sla.0000250432.35369.65.
To determine the risk of small bowel obstruction (SBO) after irradiation (RT) for rectal cancer
: SBO is a frequent complication after standard resection of rectal cancer. Although the use of RT is increasing, the effect of RT on risk of SBO is unknown.
We conducted a retrospective cohort study using Surveillance, Epidemiology, and End Results cancer registry data linked to Medicare claims data to determine the effect of RT on risk of SBO. Patients 65 years of age and older diagnosed with nonmetastatic invasive rectal cancer treated with standard resection from 1986 through 1999 were included. We determined whether patients had undergone RT and evaluated the effect of RT and timing of RT on the incidence of admission to hospital for SBO, adjusting for potential confounders using a proportional hazards model.
We identified a total of 5606 patients who met our selection criteria: 1994 (36%) underwent RT, 74% postoperatively. Patients were followed for a mean of 3.8 years. A total of 614 patients were admitted for SBO over the study period; 15% of patients in the RT group and 9% of patients in the nonirradiated group (P < 0.001). After controlling for age, sex, race, diagnosis year, type of surgery, and stage, we found that patients who underwent postoperative RT were at higher risk of SBO, hazard ratio 1.69 (95% CI, 1.3-2.1). However, the long-term risk associated with preoperative irradiation was not statistically significant (hazard ratio, 0.89; 95% CI, 0.55-1.46).
Postoperative but not preoperative RT after standard resection of rectal cancer results in an increased risk of SBO over time.
确定直肠癌放疗(RT)后发生小肠梗阻(SBO)的风险
SBO是直肠癌标准切除术后常见的并发症。尽管放疗的使用日益增加,但放疗对SBO风险的影响尚不清楚。
我们进行了一项回顾性队列研究,使用与医疗保险索赔数据相关的监测、流行病学和最终结果癌症登记数据来确定放疗对SBO风险的影响。纳入1986年至1999年期间65岁及以上诊断为非转移性浸润性直肠癌并接受标准切除治疗的患者。我们确定患者是否接受了放疗,并评估放疗及其时机对因SBO入院发生率的影响,使用比例风险模型对潜在混杂因素进行校正。
我们共识别出5606名符合我们选择标准的患者:1994名(36%)接受了放疗,其中74%在术后接受放疗。患者平均随访3.8年。在研究期间,共有614名患者因SBO入院;放疗组患者中有15%,未放疗组患者中有9%(P<0.001)。在控制了年龄、性别、种族、诊断年份、手术类型和分期后,我们发现术后接受放疗的患者发生SBO的风险更高,风险比为1.69(95%CI,1.3 - 2.1)。然而,术前放疗相关的长期风险无统计学意义(风险比,0.89;95%CI,0.55 - 1.46)。
直肠癌标准切除术后进行术后放疗而非术前放疗会随着时间推移导致SBO风险增加。